Mixed options sentiment in Novo Nordisk (NVO), with shares down 10c near $47.66. Options volume relatively light with 38k contracts traded and ...

Medicare enrollees will save more than 50% on out-of-pocket costs for 10 common prescription drugs under their insurance ...

Americans enrolled in Medicare will pay about 50% less out of pocket in 2026 for some drugs including Pfizer and Bristol ...

European shares rose on Thursday as lower-than-expected U.S. inflation strengthened hopes for Federal Reserve interest rate ...

Eli Lilly's oral pill, orforglipron, helped maintain weight loss in patients switching from injectable versions of GLP-1 ...

Eli Lilly's oral pill helped maintain weight loss in patients switching from injectable versions of GLP-1 drugs, the company ...

Wegovy maker Novo Nordisk filed for U.S. FDA approval of CagriSema, a once-weekly shot that combines two compounds to treat obesity.

Novo Nordisk said on Thursday it filed a marketing application to the U.S. Food and Drug Administration for CagriSema, its once-weekly next-generation weight-loss drug.

Eli Lilly’s decision to pour more than $6 billion into a new pharmaceutical ingredient plant in Huntsville, Alabama, caps a ...

ZURICH, Dec 18 () - Swiss pharma giants Novartis and Roche on Thursday backed U. efforts to lower the ​cost of drugs and are ...

European shares were muted on Thursday as investors adopted a largely cautious stance ahead of a series of central bank ...